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The innate immune system is essential for controlling viral infection. Hepatitis B virus 
(HBV) persistently infects human hepatocytes and causes hepatocellular carcinoma. 
However, the innate immune response to HBV infection in vivo remains unclear. Using 
a tree shrew animal model, we showed that HBV infection induced hepatic interferon 
(IFN)-γ expression during early infection. Our in vitro study demonstrated that hepatic 
NK cells produced IFN-γ in response to HBV only in the presence of hepatic F4/80+ 
cells. Moreover, extracellular vesicles (EVs) released from HBV-infected hepatocytes 
contained viral nucleic acids and induced NKG2D ligand expression in macrophages by 
stimulating MyD88, TICAM-1, and MAVS-dependent pathways. In addition, depletion 
of exosomes from EVs markedly reduced NKG2D ligand expression, suggesting the 
importance of exosomes for NK cell activation. In contrast, infection of hepatocytes 
with HBV increased immunoregulatory microRNA levels in EVs and exosomes, which 
were transferred to macrophages, thereby suppressing IL-12p35 mRNA expression 
in macrophages to counteract the host innate immune response. IFN-γ increased the 
hepatic expression of DDX60 and augmented the DDX60-dependent degradation of 
cytoplasmic HBV RNA. Our results elucidated the crucial role of exosomes in antiviral 
innate immune response against HBV.
accession number: Accession number of RNA-seq data is DRA004164 (DRA in DDBJ).
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inTrODUcTiOn
The innate immune response is the first line of defense against viral infection, and viral nucleic acids 
are recognized by pattern recognition receptors. Endosomal viral RNA and DNA are recognized 
by Toll-like receptor 3 (TLR3) and TLR7–9 (1). TLR7–9 require the MyD88 adaptor, whereas 
TLR3 requires the TICAM-1/Trif adaptor to initiate innate immune responses (1). Cytoplasmic 
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double-stranded RNA (dsRNA) is recognized by RIG-I-like 
receptors (RLRs), RIG-I, and MDA5, which require the MAVS 
adaptor to trigger signaling (2). In contrast, cytoplasmic dsDNA 
is recognized by cGAS (3, 4) and IFI16 (5), which require the 
STING adaptor for the innate immune response. DDX60 is a 
cytoplasmic RNA helicase, which functions as a cell-type specific 
sentinel for the recognition and degradation of viral RNA and 
promotes the degradation of viral RNA (6, 7).
Extracellular vesicles (EVs) include microvesicles and 
exosomes. Microvesicles are released from the plasma membrane, 
and exosomes are released upon the exocytosis of multivesicular 
bodies; and CD9, CD63, and CD81 are markers of exosomes (8). 
An extensive body of evidence has shown that exosomes medi-
ate intercellular communication (8) and also plays a crucial role 
for antiviral innate immune response. EVs including exosomes 
released from HCV-infected hepatocytes deliver viral RNA to 
dendritic cells, which is recognized by TLR3 and TLR7, resulting 
in type I interferon (IFN) production (9, 10). Moreover, exosomes 
deliver host microRNAs (miRs) and regulate the innate immune 
response to lipopolysaccharide (11). Recent studies indicate that 
not only exosomes but also microvesicles mediate intercellular 
communications (12).
Hepatitis B virus (HBV) is a major cause of hepatocellular 
carcinoma. RIG-I plays a dual role in the antiviral response 
to HBV in hepatocytes (13). RIG-I senses the ϵ region of viral 
pregenomic RNA, resulting in the production of type III IFN. 
In addition, the binding of RIG-I to the ϵ region counteracts 
the interaction between viral polymerase and pregenomic RNA, 
thereby suppressing viral replication (13). cGAS recognizes HBV 
dsDNA and induces an IFN-inducible gene, ISG56, to suppress 
viral replication in hepatocyte cell lines (14). However, the in vivo 
roles of RIG-I and cGAS in the innate immune response to HBV 
remain unclear. Type I IFN and type III IFN are well known to 
exhibit antiviral activities, but type II IFN (IFN-γ) also has anti-
viral activities against HBV, although the underlying mechanism 
is unclear (15, 16).
Hepatitis B virus infects humans and primates but not mice. 
Tree shrews (Tupaia belangeri chinensis) are small mammals that 
are susceptible to HBV infection, and the tree shrew animal model 
is a powerful tool for HBV research (17). In the present study, 
using the tree shrew animal model, we investigated the in vivo 
innate immune response to HBV. Our results demonstrated the 
crucial roles of EVs including exosomes in vivo during the innate 
immune response to HBV.
resUlTs
hBV induces hepatic iFn-γ expression 
In Vivo
To investigate the in vivo innate immune response to HBV, HBV 
infectious particles were intravenously injected to tree shrews, 
and total RNA was isolated from the liver at 0, 1, and 3 days post-
infection (Figure  1A). RNA-seq analysis was performed using 
a next-generation sequencer. A heatmap of all genes suggested 
that expression of most genes was not altered (Figure  1B and 
Figures S1A,B in Supplementary Material); however, there were 
several genes whose expression was affected by HBV injection 
(Figure  1C), and the induced expression of MAP3K2, RNase 
L, MDA5, and CD69 was detected (Figure 1C and Figure S1C 
in Supplementary Material). The IFN gene expression was not 
detected by RNA-seq analysis because of its low expression level.
To detect IFN-β, -γ, and -λ expression in tree shrew tissues, 
we performed RT-qPCR. HBV infection did not increase the 
expression of IFN-β in the liver, spleen, and kidney (Figure 1D 
and Figure S1D in Supplementary Material). In contrast, IFN-γ 
expression was specifically increased in the liver at 1 and 3 days 
post-infection (Figure  1D and Figure S1D in Supplementary 
Material). Considering that the adaptive immune response can-
not produce IFN-γ within 1 day of primary infection, this early 
IFN-γ expression suggests that group 1 innate lymphoid cells 
(ILCs) are responsible for the early IFN-γ expression. In addition, 
HBV intravenous injection increased hepatic DDX60 expression 
but not RIG-I, cGAS, or IFI16 (Figure 1D).
When hepatocyte cell lines, HepG2 and HuH-7, were trans-
fected with a plasmid, pHBV, which carries 1.4× HBV genomic 
DNA and produces pregenomic RNA and all viral proteins, HBV 
RNA appeared at 3  h after transfection. However, the expres-
sion levels of DDX60 and IFN-γ did not increase until 24  h 
after transfection (Figure 2A and Figure S1E in Supplementary 
Material). As reported previously (13), HBV increased the RIG-
I-dependent expression of IFN-λ in HuH-7 cells (Figure  2B). 
To further investigate the response of hepatic cells to HBV, we 
used primary hepatocytes and hepatic stellate cells. Infection of 
primary hepatocytes and hepatic stellate cells with HBV failed 
to increase IFN-γ and DDX60 expression (Figures  2C,D). 
These observations imply that hepatocytes and hepatic stellate 
cells cannot induce IFN-γ and DDX60 in response to HBV, and 
that non-parenchymal cells are required for hepatic IFN-γ and 
DDX60 expression.
extracellular Vesicles induce the 
expression of the nKg2D ligands in 
Macrophages
Hepatitis B virus infects hepatocytes but not non-parenchymal 
cells. Therefore, it was expected that hepatocytes would release 
the molecule that activates non-parenchymal cells. It should 
be noted that HCV-infected hepatocytes release the exosomes 
containing viral RNA, thereby leading to the activation of den-
dritic cells via TLRs (9), so we investigated whether HBV RNA is 
present in EVs including exosomes in a similar manner to HCV. 
First, we isolated EVs from cell culture medium of hepatocytes. 
We confirmed that EVs contained the CD9 protein, which is a 
marker of exosomes (Figure 3A). Interestingly, HBV RNA, but 
not host GAPDH mRNA, was detected within EVs released by 
pHBV-transfected hepatocytes (Figure 3B). Second, we isolated 
exosomes from HepG2 cell culture medium using anti-CD81 
antibody beads, because exosomes released from HepG2 contain 
CD81 (18). Using the anti-CD81 beads, we could concentrate 
exosomes, and CD81, CD9, and CD69, which are a marker of 
the exosomes, were detected in the exosomes by western blot-
ting (Figure  3C). As expected, HBV RNA was also detected 
in the CD81+ exosomes (Figure 3D), and viral DNA was also 
FigUre 1 | hBV induces hepatic iFn-γ expression. (a) Experimental procedure for infection and sampling. Tree shrews were infected intravenously with the 
HBV infectious particles. The livers were isolated on the day indicated. (B,c) Hierarchical clustering analysis of gene expression in the liver at 0, 1, and 3 days 
post-infection. Total RNA was extracted, and then RNA-seq analysis was performed using a next-generation sequencer. The data are representative of at least three 
independent experiments. The heat map of all genes was shown in (B). The clustered regions, in which the expression of genes was upregulated (left panel), 
downregulated (center pane), and not changed by infection (right panel), were shown in (c). (D) The gene expression levels in the liver of HBV-infected tree shrew 
were determined using RT-qPCR and was normalized against that of β-actin. Data are presented as mean ± SD (n = 4).
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detected in the CD81+ exosomes (Figure S2A in Supplementary 
Material). In addition, CD81+ exosomes released from HBV-
infected HepG2-NTCP cells contained HBV RNA (Figure S2D 
in Supplementary Material).
NK cells are the major group 1 ILCs in liver. In general, NK 
cells can produce IFN-γ (19), whereas Kupffer cell, which are 
hepatic macrophages, activates T and NK cells, resulting in IFN-
γ production by T or NK cells (20). Hepatic NK cells isolated 
from mice failed to produce IFN-γ in the presence of HepG2-T23 
cells, which stably express pHBV and produce HBV infectious 
particles (Figure  3E). Interestingly, hepatic NK cells produced 
IFN-γ in the presence of both HepG2-T23 and hepatic F4/80+ 
cells, which is a marker of macrophages (Figure 3E), suggesting 
the importance of macrophages. Therefore, we next, investigated 
whether EVs released from hepatocytes with pHBV affect mac-
rophage function.
FigUre 2 | The response of human hepatic cells to hBV. (a) HuH-7 cells were transfected with pHBV plasmid, and RT-qPCR analysis was performed to 
determine the expression levels of HBV RNA, IFN-β, IFN-γ, IFN-λ1, and DDX60. Data are presented as mean ± SD (n = 3). (B) HuH-7 and HuH-7.5 cells were 
transfected with a plasmid carrying 1.4× HBV genome for 24 h. IFN-λ1 expression was determined using RT-qPCR and normalized to GAPDH. Data are presented 
as mean ± SD (n = 3). (c) Human primary hepatocytes were infected with HBV for 24 h, and the expression of the genes were determined by RT-qPCR. Data are 
presented as mean ± SD (n = 4). (D) Human primary hepatic stellate cells were infected with HBV for 24 h, and the expression of the genes was determined by 
RT-qPCR. Data are presented as mean ± SD (n = 4).
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Extracellular vesicles were isolated from hepatocytes with or 
without pHBV. HBV transfection to hepatocytes barely affected 
the CD63 protein levels of EVs (Figures  3F,G). Interestingly, 
EVs released from hepatocytes with pHBV increased the mRNA 
expression of NKG2D ligands (MICA, ULBP1, ULBP2, and Rae1) 
in THP-1 macrophages or hepatic F4/80+ cells (Figures 3F,H). 
NKG2D ligands are known to elicit IFN-γ production from NK 
cells (21, 22). These data are correlated with upregulation of 
CD69, a NK cell activation marker, in tree shrew liver after HBV 
intravenous infection (Figure S1C in Supplementary Material). 
We confirmed that infection of HepG2-NTCP with HBV cells 
substantially increased the expression of ULBP1 and ULBP2 
mRNA in co-cultured THP-1 macrophages, which was cultured 
using transwell co-culture system (Figure 3I).
To assess the role of exosomes in NKG2D ligand expres-
sion, we performed a depletion assay. The depletion of CD81+ 
exosomes attenuated the EVs-mediated ULBP1 and ULBP2 
expression in THP-1 macrophages (Figure  4A), indicating the 
importance of CD81+ exosomes. Interestingly, knockdown of 
MyD88 reduced EVs-mediated ULBP1 and ULBP2 expression, 
and ULBP2 expression was also reduced by TICAM-1 or VISA 
knockdown (Figure 4B). These results indicate that the CD81+ 
exosomes stimulate the MyD88, TICAM-1, and VISA pathways. 
Knockdown of PYCARD moderately decreased the expression of 
ULBP2 (Figure 4B); however, the ULBP2 expression was induced 
by TLRs and RLRs stimulation even in the absence of PYCARD 
stimulation (see below).
microrna (mir) within eVs controls 
the host innate immune response
To investigate whether exosomal nucleic acids are sufficient for 
the NKG2D ligand expression, exosomal RNA and DNA were 
extracted from exosomes released from HepG2 cells with pHBV, 
and THP-1 macrophages were stimulated with exosomal nucleic 
FigUre 3 | exosomes containing viral rna induce nKg2D ligand expression in macrophages. (a) HepG2 cells were seeded onto a 24-well plate and 
cultured for 24 h. EVs were isolated from 0.5 ml of cell culture medium using a polyethylene glycol method with exosome isolation kit (see Isolation of Exosomes in 
Experimental Procedures) and suspended with 150 μl of 1× SDS sample buffer. The 150 μl of whole cell extract (WCE) were prepared from cultured cells. The 10 μl of 
EVs and 10 μl of WCE were subjected to SDS-PAGE. CD9 and β-actin proteins were detected by western blotting with anti-CD9 antibody and anti-β-actin antibody.  
(Continued)
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FigUre 4 | The role of exosomes in the activation of Prrs. (a) EVs released from HepG2 cells transfected with mock or pHBV was treated with or without 
anti-CD81 antibody beads (α-CD81 beads) and was subsequently added to THP-1 macrophages for 24 h. ULBP1 and ULBP2 mRNA expression in THP-1 
macrophages were determined by RT-qPCR and normalized to GAPDH. Data are presented as mean ± SD (n = 3). (B) THP-1 macrophages were transfected with 
siRNA for mock, TICAM-1, VISA, MyD88, and PYCARD and were subsequently treated with EV from HepG2 with or without HBV for 24 h. ULBP1 and ULBP2 
mRNA expression in THP-1 macrophages were determined by RT-qCR and normalized to GAPDH. Data are presented as mean ± SD (n = 3).
(B) Extracellular vesicles (EVs) released from HepG2 (left) or HuH-7 (right) transfected with pHBV were collected, and the total RNA was extracted. The RNA 
levels of HBV RNA and GAPDH mRNA were determined by RT-qPCR and normalized against that of U6 RNA. Data are presented as mean ± SD. (c) Exosomes 
were isolated from EVs released from HepG2 cells using anti-CD81 antibody beads. WCE, EVs, and 10× concentrated exosomes were subjected to SDS-
PAGE, and the proteins were detected by western blotting. (D) The CD81+ exosomes were isolated from EVs with anti-CD81 microbeads. The RNA levels were 
determined as described in (B). Data are presented as mean ± SD (n = 3). (e) Hepatic F4/80+ cells and hepatic NK cells were co-cultured with normal HepG2 
cells or HepG2-T23 cells (HepG2-HBV), which stably express HBV, for 1 day. IFN-γ levels in the culture supernatants were determined using ELISA (n > 3). (F) 
EVs released from HuH-7 or HepG2 with or without HBV were added to PMA-treated THP-1 cells (THP-1 macrophages) for 24 h. The expression of mRNA in 
THP-1 macrophages was determined by RT-qPCR and normalized to GAPDH (n = 3). (g) HepG2 cells in six-well plates were transfected with mock or pHBV 
and were cultured for 24 h. EVs were isolated from 5 ml of culture medium and were suspended with 100 μl of PBS. The 5 μl of EVs were mixed with 5 μl of 2× 
SDS sample buffer and were subjected to SDS-PAGE. The proteins were detected by western blotting with anti-CD63 antibody. (h) EVs released from HepG2 
with or without HBV were added to mouse hepatic F4/80+ cells for 24 h. The expression of mRNA in hepatic F4/80+ cells was determined by RT-qPCR and 
normalized to GAPDH (n = 3). (i) HepG2-NTCP cells were infected with HBV for 9 days and were subsequently co-cultured with THP-1 (transwell co-culture) for 
3 days. The expression of mRNA in THP-1 macrophages was determined by RT-qPCR.
FigUre 3 | continued
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acids. The expression of ULBP2 in THP-1 macrophages was sub-
stantially increased by stimulation with exosomal RNA and DNA 
(Figure  5A). Viral RNA and DNA are well known to activate 
MyD88, TICAM-1, and VISA pathways, and thus, we investi-
gated whether stimulation of TLRs and RLRs pathway mimics 
EVs that were released from HBV-infected cells. To stimulates the 
TLR3–TICAM-1 pathway, 50 μg of polyI:C was added to culture 
medium, and 1 μg of polyI:C was transfected to stimulate the 
RLRs–VISA pathway. For stimulation of TLR7 and TLR9, which 
trigger the signal via MyD88, 1 μg/ml of CL097 and 500 μM 
of ODN2216 were added to cell culture medium, respectively. 
The simultaneous stimulation of all four pathways with TLR3/
RIG-I/MDA5, TLR7, and TLR9 ligands (polyI:C, CL097, and 
ODN2216) induced the expression of IL-12p35 as well as ULBP1 
FigUre 5 | exosomes with mir attenuates the il-12p35 mrna expression. (a) CD81+ exosomes were isolated from HepG2 with pHBV. Mock or 5 μg of 
exosomal RNA was added to THP-1 macrophages for 6 h, and then cells were transfected with mock or 1 μg of exosomal RNA and 1 μg of DNA for 24 h. ULBP2 
mRNA expression was determined by RT-qPCR and normalized to GAPDH. (B) PMA-treated THP-1 cells were stimulated with 500 μM of ODN2216, 1 μg/ml of 
CL097, and/or polyI:C [transfection (2 μg/ml) and addition (100 μg/ml)] for 24 h. The expression of mRNA was determined by RT-qPCR. (c,D) RNA was extracted 
from EVs and CD81+ exosomes released from HepG2 with or without HBV (c) or HBV-infected HepG2-NTCP cells (D), and the expression of miR was determined 
by RT-qPCR and normalized to U6 RNA level. Fold increase of miR expression was calculated by dividing miR level of HBV sample by that of mock. (e) THP-1 
macrophages were treated with IFN-γ together with mock or EVs that were isolated from 1 ml of HepG2 cell culture medium for 24 h in a 24-well plate and were 
subsequently stimulated with 1 μg/ml of CL097 and polyI:C [transfection (2 μg/ml) and addition (100 μg/ml)] for 24 h. IFN-β and IL-12p40 mRNA expression was 
(Continued)
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determined by RT-qPCR and normalized to GAPDH. (F) EVs were isolated from 1 ml of cell culture medium of HepG2 with or without pHBV. THP-1 macrophages 
were treated with EVs and were then simulated with 500 μM of ODN2216, 1 μg/ml of CL097, and polyI:C [transfection (2 μg/ml) and addition (100 μg/ml)] for 24 h in 
a 24-well plate. The expression of IFN-β and IL-12p35mRNA in THP-1 macrophages was determined by RT-qPCR and normalized to GAPDH. (g) EVs were 
isolated from 1 ml of cell culture medium of HepG2 cells. THP-1 macrophages were treated with EVs from HepG2 cells with or without pHBV for 24 h in a 24-well 
plate. Cells were washed twice with PBS, and total RNA was extracted from THP-1 cells. The expression of miR in THP-1 macrophages was determined by 
RT-qPCR. (h) HepG2 cells were transfected with miR-29a for 1 day, and EVs were subsequently isolated from HepG2 cell culture supernatant. THP-1 macrophages 
were treated with EVs for 1 day and then stimulated with 1 μg/ml of CL097 and polyI:C [transfection (2 μg/ml) and addition (100 μg/ml)] for 24 h. IL-12p40 mRNA 
expression was determined by RT-qPCR. Data are presented as mean ± SD (n ≥ 3).
FigUre 5 | continued
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and ULBP2, whereas the stimulation of each separate pathway 
failed to increase the expression levels (Figure  5B and Figures 
S3A,B in Supplementary Material). IL12-p40 mRNA expression 
was increased by stimulation with both polyI:C (addition and 
transfection) and CL097, even in the absence of ODN2216 
(Figure S3B in Supplementary Material). Given that EVs released 
by hepatocytes with pHBV did not increase IL-12p35 mRNA 
expression in THP-1 macrophages (Figure 3F), we hypothesized 
that EVs contain the agonists for each pathway as well as other 
molecules that regulate innate immune response.
The exosomes deliver miR to other cells and regulate the innate 
immune response (11). Thus, we investigated the expression 
levels of 17 immunoregulatory miRs within EVs and exosomes 
(23). Interestingly, HBV increased the expression levels of miR-21 
and miR-29a in EVs and CD81+ exosomes (Figure 5C and Figure 
S3C in Supplementary Material). Moreover, exosomal miR-21 
and miR-29a levels were markedly increased by infection of 
HepG2-NTCP cells with HBV (Figure 5D). miR-21 downregu-
lates IL-12p35 mRNA expression (24) and is induced by the HBx 
proteins (25). miR-29a is known to suppress IL-12p40 mRNA 
expression (26).
Interestingly, EVs released from hepatocytes reduced 
IL-12p40, but not IFN-β expression, in THP-1 macrophages 
that were stimulated with CL097 and polyI:C (addition and 
transfection) (Figure 5E). Moreover, EVs released from HepG2 
with pHBV reduced stimulation-induced IL-12p35 expression 
in THP-1 macrophages compared to EVs from HepG2 without 
pHBV (Figure  5F). We confirmed that the expression of HBV 
in hepatocytes increased the levels of miR-21, miR-29a, and 
other immunoregulatory miRs in THP-1 macrophages via 
EVs (Figure  5G). In addition, miR-29a transfection to THP-1 
macrophage decreased IL-12p40 expression (Figure S3D in 
Supplementary Material), and EVs released from hepatocytes that 
were transfected with miR-29a decreased IL-12p40 expression in 
THP-1 macrophages (Figure 5H). Overall, these results indicate 
that HBV-induced immunosuppressive miRs were transferred to 
macrophages from hepatocytes, thereby suppressing the IL-12 
expression.
Hepatitis B virus intravenous infection increased the expres-
sion of a NKG2D ligand, ULBP3, in tree shrew liver but failed to 
increase IL-12p35 and IL-12p40 in vivo (Figure 1D). These data 
are nicely correlated with our in vitro studies.
iFn-γ Promotes Viral rna Degradation 
in hepatocytes
IFN-γ itself has many functions, such as promotion of Th1 dif-
ferentiation and macrophage activation. A previous study showed 
that IFN-γ destabilizes viral RNA (15); however, underlying 
mechanism is not fully elucidated. To investigate the physiologi-
cal meaning of EVs-induced IFN-γ production in antiviral innate 
immune response, we sought to assess the role of IFN-γ in viral 
RNA degradation. To observe viral RNA degradation, HepG2 
cells were transfected with pHBV, and viral RNA expression was 
attenuated by actinomycin D (ActD), and then viral RNA levels 
were determined by RT-qPCR. As previously reported, IFN-γ 
treatment promoted the degradation of viral RNA (Figure 6A). 
Interestingly, IFN-γ treatment increased the DDX60 mRNA and 
protein levels in hepatocytes (Figures 6B–E). It has been shown 
that DDX60 is involved in a viral RNA degradation pathway (6). 
The ectopic expression of DDX60 promoted the degradation of 
HBV RNA (Figure 6F). In contrast, DDX60 knockdown delayed 
the degradation of HBV RNA (Figures  6G,H). Interestingly, 
cytoplasmic viral RNA was degraded faster than nuclear viral 
RNA, and DDX60 knockdown delayed the degradation of 
cytoplasmic viral RNA but not nuclear viral RNA (Figures 6I,J). 
These data suggest that IFN-γ induces the expression of DDX60, 
which promotes viral RNA degradation.
Next, we assessed the role of DDX60 in viral replication. The 
ectopic expression of DDX60 decreased the HBV RNA levels in 
hepatocytes with pHBV (Figure  6K), and DDX60 knockdown 
substantially increased HBV RNA levels (Figure 6L). The HBsAg 
levels were also reduced in the culture medium by DDX60 ectopic 
expression (Figure 6M). IFN-γ-treatment reduced HBsAg, and 
the IFN-γ-mediated reduction of HBsAg was alleviated by DDX60 
knockdown (Figure 6N), thereby suggesting the importance of 
DDX60 in the IFN-γ-antiviral activity against HBV.
Next, we further assessed the role of DDX60 during viral 
infection. IFN-γ treatment reduced the viral RNA levels in HBV-
infected HePG2-NTCP cells (Figure S4A in Supplementary 
Material), and DDX60 knockdown increased the HBV RNA levels 
in cells infected with HBV for 6 days (Figure 6O). Collectively, 
these results indicate that DDX60-mediated HBV RNA deg-
radation suppresses viral replication. Using a hydrodynamic 
injection mouse model, we confirmed that IFN-γ treatment 
could reduce the serum HBsAg level in vivo after HBV injec-
tion into mouse liver (Figure S4B in Supplementary Material). 
These results support a model that exosomes-mediated hepatic 
IFN-γ production plays a crucial role in antiviral innate immune 
response to HBV.
DiscUssiOn
In the present study, we elucidated the early in  vivo innate 
immune response to HBV infection in tree shrews. IFN-γ 
FigUre 6 | DDX60 promotes cytoplasmic hBV rna degradation. (a) HuH-7 cells transfected with pHBV were treated with 10 ng/ml of IFN-γ for 1 day. 
Cells were treated with actinomycin D (ActD), and then HBV RNA degradation was determined by RT-qPCR and normalized to GAPDH. (B) HuH-7 and HepG2 
cells were stimulated with 10 ng/ml of IFN-γ. Total RNA was extracted at indicated time points, and mRNA levels were determined by RT-qPCR and normalized 
to GAPDH. Data are presented as mean ± SD (n = 3). (c) HepG2-T23 cells were transfected with pHBV for 24 h. Cells were stimulated with 10 ng/ml of IFN-γ, 
and the expression of DDX60 was determined by RT-qPCR. Data are presented as mean ± SD (n = 3). (D) HepG2-NTCP cells were stimulated with 10 ng/ml of 
(Continued)
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IFN-γ, and whole cell extract was prepared at indicated time points. The proteins were subjected to SDS-PAGE and were detected by western blotting with anti-
DDX60 and anti-β actin antibodies. (e) HepG2-NTCP cells were fixed and labeled with anti-DDX60 antibody. Cells were stained with DAPI and Alexa Fluor-488 
secondary antibody and were observed using confocal microscopy. The scale bar represents 10 μm. (F–J) HuH-7 cells transfected with pHBV together with an 
empty vector or a DDX60 expression vector (F) or siRNA for control or DDX60 (g–J) were treated with ActD. Total RNA (F–h), nuclear RNA (i), and cytoplasmic 
RNA (J) were extracted at indicated time points. HBV RNA levels were determined using RT-qPCR and normalized to GAPDH (n = 3). (K–M) HuH-7 cells 
transfected with the combination of pHBV and either an empty vector or a DDX60 expression vector (K,M) or with pHBV and an siRNA (as a negative control) or 
DDX60 (l). Four days after transfection, total RNA was extracted, and HBV RNA and DDX60 mRNA levels were determined by RT-qPCR and normalized to 
GAPDH (K,l). HBsAg levels in the culture medium 2 days after transfection were determined using ELISA (M). (n) siRNA for control or DDX60 was transfected 
into HuH-7 cells with the HBV plasmid. Two days after transfection, cells were washed with fresh medium and subsequently treated with or without 10 ng/ml 
IFN-γ for 2 days. HBsAg levels in culture medium were determined by ELISA. (O) HepG2-NTCP cells were infected with infectious HBV particles for 6 days. 
Total RNA was extracted from the HBV-infected cells. HBV RNA and DDX60 mRNA levels were determined using RT-qPCR and normalized to GAPDH. Data are 
presented as mean ± SD (n ≥ 3).
FigUre 6 | continued
10
Kouwaki et al. Extracellular Vesicles Regulate Innate Immunity
Frontiers in Immunology | www.frontiersin.org August 2016 | Volume 7 | Article 335
was induced in the liver at 1 day post-infection, and this early 
production of IFN-γ suggests the importance of hepatic group 
1 ILCs for the in  vivo innate immune response. Experimental 
tree shrew infection with HBV was successful in approximately 
55% of the animals inoculated, whereas the remaining animals 
rejected HBV (27), suggesting that the antiviral innate immune 
response in tree shrews has the ability to eliminate HBV. The 
major group 1 ILCs in liver is NK cells, and we determined that 
hepatic NK cells were activated in the presence of hepatic F4/80+ 
cells. This is consistent with the upregulation of CD69, an NK 
cell activation marker, in tree shrew liver after HBV infection. 
However, we do not exclude the possibility that not only NK 
cells but also other types of cells produced IFN-γ. In woodchuck 
animal model, woodchucks infected with closely related wood-
chuck hepatitis virus also showed the upregulation of NKp46, 
an NK cell activating receptor, immediately after infection (28). 
Chisari and colleagues first implied the importance of NK cell 
influx for early non-cytopathic control of HBV based on a study 
using a chimpanzee animal model (29). Accumulating evidence 
indicates that NK cells are major determinants of the clinical 
outcome following infection with HBV (30), and NK cells have 
been reported to control HBV infection in humans (31, 32). 
Considering these observations, we prefer the interpretation that 
HBV infection activates hepatic NK cells, resulting in the early 
IFN-γ production in the liver. Although hepatic IFN-γ expres-
sion levels increased only 20-fold after infection of tree shrews 
with HBV, non-parenchymal cells would produce much more 
amount of IFN-γ after HBV infection, because parenchymal cells 
do not produce IFN-γ.
There are several reports indicating that IFN-γ exhibits 
antiviral activity against HBV. For example, knockout of IFN-γ 
increased HBV replication in mouse liver (33), and IFN-γ expres-
sion inhibited HBV replication in vitro (34). Previously, Chisari 
and colleagues showed that IFN-γ and TNF-α destabilize viral 
RNA and abolish HBV gene expression and replication in the 
liver without killing hepatocytes (15). Here, we demonstrated 
that IFN-γ induces DDX60 expression in hepatocytes, leading 
to DDX60-mediated HBV RNA degradation. We also showed 
that DDX60 deficiency leads to increased HBV RNA levels. 
These findings reveal the molecular mechanism underlying the 
IFN-γ-mediated destabilization of viral RNA. Recently, Protzer 
and colleagues reported that TNF-α and IFN-γ induce the 
deamination of covalently closed circular HBV DNA, resulting 
in HBV DNA instability (35). These observations suggest that 
IFN-γ together with TNF-α destabilizes viral RNA and DNA. A 
previous study showed that ZAP(S) is involved in nuclear HBV 
RNA degradation via the ribonuclease complex (36), whereas we 
showed that DDX60 is involved in not nuclear but cytoplasmic 
viral RNA degradation. These observations indicate that DDX60 
has a distinct role in viral RNA degradation.
Extracellular vesicles, including exosomes, have important 
functions in intercellular communication (37), and exosomes 
deliver HCV RNA to dendritic cells, thereby inducing the 
innate immune response (38). Here, we demonstrated that 
EVs released from HBV-infected hepatocytes contained viral 
nucleic acids, and exosomal viral nucleic acids stimulated 
macrophages. These observations indicate that EVs including 
exosomes play a crucial role in the innate immune response 
against HBV.
Several viruses have evolved to escape the host innate 
immune response. Recent studies have revealed the molecular 
mechanism underlying viral escape from the host innate 
immune response (39). It has been shown that HBV increases 
miR-21 expression in hepatocytes (25). Here, we showed that 
exosomal miR-21 as well as other immunosuppressive miRs 
were increased by the HBV infection of hepatocytes, and these 
exosomal miRs downregulated IL-12 expression, which is a 
cytokine well known to activate NK cells. In another animal 
model, woodchuck hepatitis virus infection led to only a tempo-
rary expression of IL-12 at 3–6 h post-infection in woodchuck 
liver, and IL-12 expression was not detected 18 h after infection 
or at any later time points up to 2 weeks (28). In addition, in 
chronic hepatitis B patients, NK cell function has been reported 
to be attenuated by HBV infection (40). Exosome-mediated 
IL-12 downregulation would be a mechanism of viral escape 
from the host innate immune response. Recently, it has been 
shown that serum exosomes isolated from patients chronically 
infected with HBV regulates NK cell function (41). This suggests 
that exosomes regulate the innate immune system during not 
only the early phase but also the chronic phase of viral infection. 
The balance between the host innate immune response and 
virus-mediated suppression might determine whether HBV 
persistently infects the liver.
Overall, our results provide novel insights into the molecular 
mechanisms underlying EVs-mediated innate immune response 
during viral infection.
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eXPeriMenTal PrOceDUres
animals
Tree shrews (T. belangeri chinensis) were injected intravenously 
with 107 copies of infectious HBV particles (C_JPNAT, accession 
number: AB246345.1). Tissues were extracted at days 0, 1, and 3. 
Total RNA was extracted with TRIzol (Invitrogen). C57BL/6 and 
BALB/c mice were purchased from Hokudo and SANKYO LABO 
SERVICE. All of the animal studies were conducted in strict 
accordance with the Guidelines for Animal Experimentation of 
the Japanese Associations for Laboratory Animal Science. The 
protocols were approved by the Animal Care and Use Committee 
of Hokkaido University, Japan (permit numbers: 09-0215, 
13-0049, and 15-0017) and the ethics committee of the Tokyo 
Metropolitan Institute of Medical Science.
cells, Virus, and reagents
C57BL/6 mouse liver was dissociated into single-cell suspensions 
using a Liver Dissociation Kit (Miltenyi Biotec), according to the 
manufacturer’s instructions. Hepatic F4/80+ cells were isolated 
using anti-F4/80-biotin antibody and anti-biotin MicroBeads 
(Miltenyi Biotec). Liver NK cells were isolated using an NK cell 
isolation kit II (Miltenyi Biotec), according to the manufacturer’s 
instruction. THP-1 cells were purchased from JCRB cell bank 
and cultured in RPMI-1640 with 5% FCS. THP-1 cells were dif-
ferentiated into macrophages with 60 ng/ml of PMA for 16 h. For 
stimulation of THP-1 macrophages, ODN2216 (500 μM), CL097 
(1 μg/ml), and polyI:C (50 μg/ml) were added to cell culture, 
or polyI:C (50 μg/ml) were transfected into cells using 2 μl of 
lipofectamine 2000 (addition and transfection) in 24-well plate. 
For activating VISA pathway, 1 μg of polyI:C were transfected 
into cells in 24-well plate. HepG2-NTCP cells were cultured with 
D-MEM/F-12 + GlutaMax with 10 mM HEPES, 200 U/ml peni-
cillin, 200 μg/ml streptomycin, 10% FCS, 50 μM hydrocortisone, 
and 5 μg/ml insulin. HepG2-T23 cells, which stably express HBV, 
were kindly donated by Chayama (Hiroshima University) (42). 
HepG2-NTCP cells, which stably express NTCP for the HBV 
receptor, were donated by Watashi (NIID) (43). Human primary 
hepatocytes and human primary hepatic stellate cells were pur-
chased from ScienCell Research Laboratories. We used human 
and mouse IFN-γ (Cell Signaling Technology), actinomycin D 
(Life Technologies), anti-DDX60 antibody (SIGMA-Aldrich), 
anti-β-actin antibody (AC-15: SIGMA-Aldrich), and an HBsAg 
ELISA kit (XpressBio). ExoAB antibody kit, which includes anti-
CD9, anti-CD63, and anti-CD81 antibodies, was purchased from 
System Biosciences.
confocal Microscopy
HepG2-NTCP cells were treated with 10  ng/ml of IFN-γ for 
8 h. Cells were washed with PBS, fixed with formaldehyde, and 
permeabilized with 0.2% of Triton-X 100 in PBS. Cells were 
subsequently blocked with 1% of BSA in PBS for 10 min and then 
incubated with anti-DDX60 rabbit polyclonal antibody (SIGMA-
Aldrich) at 1/100 dilution. Cells were washed 4× with 1% of BSA 
in PBS and stained with Alexa Fluor 488 anti-rabbit antibodies. 
Cells were embedded with ProLong Gold Antifade Mountant 
with DAPI (Life Technologies).
rna-seq
Total RNA extracted from tissues of tree shrew was extracted using 
TRIZOL (Invitrogen), according to the manufacturer’s instruc-
tion. RNA-seq libraries were prepared using TruSeq RNA-seq kit 
(illumina). Sequencing libraries were sequenced on MiSeq using 
MiSeq sequencing reagent kit ver2 (illumina), according to the 
manufacturer’s instruction. The RNA-seq tags were then mapped 
to the reference transcripts of Tupaia chinensis. Normalization 
and transformation of expression values and hierarchal cluster-
ing analysis were carried out using CLC genomics workbench 
software. RNA-seq data have been deposited to DRA in DDBJ 
(accession number: DRA004164).
elisa
NK and F4/80+ cells were isolated from mouse liver. The 1 × 106 
NK cells and 1 × 106 F4/80+ cells were co-cultured with 2 × 105 
HepG2 cells expressing HBV for 24  h. Culture supernatant 
was collected and analyzed for mouse IFN-γ by ELISA (GE 
Healthcare). Concentration of HBV surface antigen (HBsAg) 
in the serum and culture supernatant was quantified by ELISA, 
according to the manufacturer’s instruction (XpressBio).
hydrodynamic injection
Hydrodynamic injection was performed with TransIT-EE 
Hydrodynamic Delivery Solution (Takara), as described previ-
ously (44).
isolation of exosomes
HepG2 or HuH-7 cells cultured in 60-mm dish were washed 
twice with serum-free medium and further incubated with 
serum-free medium for 24 h. Culture supernatant was recov-
ered and centrifuged at 2000 rpm for 30 min to remove debris. 
Obtained supernatant was mixed with total exosome isolation 
solution and incubated at 4°C for 24 h, according to the manu-
facturer’s instruction (Thermo Fisher Scientific). Mixture was 
centrifuged at 1000 × g for 1 h, and then pellet was suspended 
with 0.5  ml of serum-free medium. The 0.1  ml of suspended 
exosome solution was added to 1 well of 24-well plate to activate 
THP-1 cells. CD81+ exosomes were isolated using cell culture 
total exosome isolation kit and CD81+ exosome isolation kit, 
according to the manufacturer’s instruction (Thermo Fisher 
Scientific).
hBV rna Decay
The plasmid carrying the 1.4× HBV genome (HBV plasmid), 
in which HBV RNA is transcribed from the pCMV minimal 
promoter, was kindly gifted by Chayama. The DDX60 expres-
sion vector has been described elsewhere (6). HuH-7 cells were 
transfected with 0.2  μg of HBV plasmid using Lipofectamine 
2000 reagent (Invitrogen). One to 3 days after transfection, the 
cells were treated with 10 μg/ml actinomycin D in order to inhibit 
HBV RNA transcription. Total RNA was extracted with the 
TRIZOL reagent (Invitrogen), according to the manufacturer’s 
instructions. Cytoplasmic and nuclear RNA were extracted with 
the Cytoplasmic and Nuclear RNA purification kit (NORGEN 
BIOTEK CORP.), according to the manufacturer’s instructions. 
Viral RNA levels were determined by qPCR.
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